1 Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125. Accessed July 24, 2025.
2 Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration Clinical Trial. Clinical Ophthalmology. 2022;16:1541-53. Accessed July 24, 2025.
3 Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263. Accessed July 2025, 2025.
4 Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328. Accessed July 24, 2025.
5 Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438. Accessed July 24, 2025.
6 Zhang H, Gong R, Zhang X, Deng Y. Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation. Int Ophthalmol. 2022 Nov;42(11):3625-3641. doi: 10.1007/s10792-022-02355-w. Epub 2022 Jun 22. PMID: 35731355; PMCID: PMC9587946. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC9587946/. Accessed July 24, 2025.